Open-Label Placebo Treatment for Acute Postoperative Pain
Status:
Recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
This study is to evaluate whether the amount of morphine intake in acute postoperative pain
following minimally invasive Transforaminal Lumbar Interbody Fusion (TLIF) can be decreased
with an Open-Label Placebo (OLP) intervention (comprising the administration of sodium
chloride (NaCl) injections and an evidence-based treatment rationale) in comparison to a
"Treatment As Usual" (TAU) control group.